Thursday, 8 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Jubilant Pharmova Ltd

NSE: JUBLPHARMA · BSE: 530019 · Pharmaceuticals & Biotechnology · 29 announcements

Share price
₹974.60
Market cap
₹15,524 Cr
Revenue (annual)
₹8,280 Cr
Net profit (annual)
₹398.5 Cr
P/E (TTM)
44.1×Sector 47.3×
Promoter holding
47.68%+0.00% QoQ
FII holding
15.87%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

20:05 IST BSE
Annual General Meeting

Jubilant Pharmova Annual General Meeting

Jubilant Pharmova held its 48th Annual General Meeting on August 26, 2026, via video conferencing. Shareholders approved all agenda items, including the final dividend declaration.

19:44 IST BSE
Annual General Meeting

Jubilant Pharmova Annual General Meeting

Jubilant Pharmova shareholders approved the re-appointment of Mr. Priyavrat Bhartia as MD and Mr. Arjun Shanker Bhartia as Joint MD via postal ballot.

22:20 IST BSE
Annual General Meeting

Jubilant Pharmova Annual General Meeting

Jubilant Pharmova Limited has issued a notice for its 48th Annual General Meeting, scheduled for August 26, 2026, including the annual report for FY 2025-26.

19:33 IST BSE
Annual General Meeting

Jubilant Pharmova Annual General Meeting

Jubilant Pharmova has issued a Postal Ballot Notice seeking shareholder approval for the re-appointment of its Managing Director and Joint Managing Director.